UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Confirmation of local water structure confined in ionic liquids using H/D exchange

Journal of molecular liquids, 2019-07, Vol.286, p.110874, Article 110874

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis

World journal of gastroenterology : WJG, 2015-02, Vol.21 (6), p.1880-1886

2015

Link zum Volltext

Verfügbarkeit prüfen

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA

BMC gastroenterology, 2013-02, Vol.13 (1), p.27-27, Article 27

2013

Link zum Volltext

Verfügbarkeit prüfen

Prospective postsurgical capsule endoscopy in patients with Crohn’s disease

World journal of gastrointestinal endoscopy, 2014-03, Vol.6 (3), p.88-98

2014

Link zum Volltext

Verfügbarkeit prüfen

Estimation of the slow hydrogen–deuterium exchange rates for local water confined in 1-butyl-3-methylimidazolium tetrafluoroborate via nuclear magnetic resonance

Journal of molecular liquids, 2022-11, Vol.365, p.120134, Article 120134

2022

Link zum Volltext

Verfügbarkeit prüfen

Relevance of the Processed Blood Volume per Granulocyte and Monocyte Apheresis Session to its Clinical Efficacy in Patients With Ulcerative Colitis

Therapeutic apheresis and dialysis, 2011-08, Vol.15 (4), p.360-366

2011

Link zum Volltext

Verfügbarkeit prüfen

A treatment indicator revision plan of the ulcerative colitis

Nihon rinshō, 2012-02, Vol.70 Suppl 1, p.294

2012

Link zum Volltext

Verfügbarkeit prüfen

Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile

Cytotherapy (Oxford, England), 2014-06, Vol.16 (6), p.821-825

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Time Of Meal Consumption on Pharmacokinetics and the Clinical Efficacy of Oral Tacrolimus in Refractory Ulcerative Colitis: P-133

Inflammatory bowel diseases, 2012-12, Vol.18, p.S68

2012

Link zum Volltext

Verfügbarkeit prüfen

Capsule Endoscopy for Assessing Small Bowel Residual Lesions at Resection and Postsurgical Recurrence in Crohnʼs Disease: P-103

Inflammatory bowel diseases, 2012-12, Vol.18, p.S55-S56

2012

Link zum Volltext

Verfügbarkeit prüfen

Long term outcome of top-down therapy in Crohnʼs disease: A single-center experience: P-119

Inflammatory bowel diseases, 2011-12, Vol.17, p.S49-S50

2011

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Advances in Immunotherapies for Hematological Malignancies

International journal of molecular sciences, 2022-09, Vol.23 (19), p.11526

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients

International journal of hematology, 2022-04, Vol.115 (4), p.489-498

2022

Link zum Volltext

Verfügbarkeit prüfen

Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis

International journal of hematology, 2019-10, Vol.110 (4), p.419-430

2019

Link zum Volltext

Verfügbarkeit prüfen

Vandetanib in patients with previously treated RET -rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

The lancet respiratory medicine, 2017-01, Vol.5 (1), p.42-50

2017

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations

Journal of blood medicine, 2019-07, Vol.10, p.171-181

2019

Link zum Volltext

Verfügbarkeit prüfen

A microchip flow‐chamber assay screens congenital primary hemostasis disorders

Pediatrics international, 2021-02, Vol.63 (2), p.160-167

2021

Link zum Volltext

Verfügbarkeit prüfen

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro

Journal of thrombosis and haemostasis, 2019-01, Vol.17 (1), p.126-137

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system

International journal of hematology, 2020-03, Vol.111 (3), p.369-377

2020

Link zum Volltext

Verfügbarkeit prüfen

Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro

Thrombosis research, 2024-05, Vol.237, p.37-45

2024

Link zum Volltext

Verfügbarkeit prüfen

Estrous detection by monitoring ventral tail base surface temperature using a wearable wireless sensor in cattle

Animal reproduction science, 2017-05, Vol.180, p.50-57

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer

Cancer science, 2017-05, Vol.108 (5), p.1000-1006

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline　― A Multicenter Validation Study

Circulation Journal, 2020/11/25, Vol.84(12), pp.2158-2165

2020

Link zum Volltext

Verfügbarkeit prüfen

EARLY-PHASE PHOTOMETRY AND SPECTROSCOPY OF TRANSITIONAL TYPE Ia SN 2012ht: DIRECT CONSTRAINT ON THE RISE TIME

Astrophysical journal. Letters, 2014-02, Vol.782 (2), p.1-6

2014

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan

International journal of hematology, 2022-02, Vol.115 (2), p.163-172

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Confirmation of local water structure confined in ionic liquids using H/D exchange

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA

Prospective postsurgical capsule endoscopy in patients with Crohn’s disease

Estimation of the slow hydrogen–deuterium exchange rates for local water confined in 1-butyl-3-methylimidazolium tetrafluoroborate via nuclear magnetic resonance

Relevance of the Processed Blood Volume per Granulocyte and Monocyte Apheresis Session to its Clinical Efficacy in Patients With Ulcerative Colitis

A treatment indicator revision plan of the ulcerative colitis

Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile

Effect of Time Of Meal Consumption on Pharmacokinetics and the Clinical Efficacy of Oral Tacrolimus in Refractory Ulcerative Colitis: P-133

Capsule Endoscopy for Assessing Small Bowel Residual Lesions at Resection and Postsurgical Recurrence in Crohnʼs Disease: P-103

Long term outcome of top-down therapy in Crohnʼs disease: A single-center experience: P-119

Therapeutic Advances in Immunotherapies for Hematological Malignancies

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients

Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis

Vandetanib in patients with previously treated RET -rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations

A microchip flow‐chamber assay screens congenital primary hemostasis disorders

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro

Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system

Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro

Estrous detection by monitoring ventral tail base surface temperature using a wearable wireless sensor in cattle

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer

Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline　― A Multicenter Validation Study

EARLY-PHASE PHOTOMETRY AND SPECTROSCOPY OF TRANSITIONAL TYPE Ia SN 2012ht: DIRECT CONSTRAINT ON THE RISE TIME

Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan

Suchergebnisse filtern